NCT01206660

Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis

A Double-Blind, Vehicle-Controlled, Randomized, Parallel Design, Multiple-Site Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone 0.25% Topical Spray in Patients With Moderate to Severe Plaque Psoriasis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: Sun Pharmaceutical Industries, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to demonstrate that desoximetasone 0.25% topical spray is effective for the treatment of patients with moderate to severe plaque psoriasis.

Conditions

• Psoriasis

Interventions

Type	Name	Description
DRUG	Desoximetasone Spray 0.25%	Desoximetasone topical spray 0.25% administered to affected area twice a day for 28 days
DRUG	placebo	Placebo administered to affected area twice a day for 28 days

Timeline

• Start date: 2010-08-01
• Primary completion: 2010-12-01
• Completion: 2011-01-01
• First posted: 2010-09-22
• Last updated: 2014-07-03
• Results posted: 2014-07-03

Locations

1 site across 1 country: United States